Andrew Campbell

Andrew Campbell, MD, is the Director of the Comprehensive Sickle Cell Program at Children’s National Health System in Washington DC. Before his move to Washington, he directed the University of Michigan Comprehensive Pediatric Hemoglobinopathies Program and was the Co-Director of the Minority Health International Research Training Program at the University of Michigan Medical School, Center for Human Growth and Development. He also directed a Fogarty Grant Training Program focusing on health disparities affecting Child Health. He is a Faculty Member and Mentor of the Northern Pacific Global Health Research Fellows Training Consortium, Ghana Site. His projects include Translational Research (Vascular Biology) in Ghanaian Sickle Cell Patients with the Department of Physiology at the University of Ghana Medical School and Health Outcomes research in the Sickle Cell Clinic in Accra, Ghana. For the past several years he has focused his research on understanding the varied phenotypic expression of sickle cell disease in different populations through the multinational Consortium for the Advancement of Sickle Cell Disease Research (CASiRe) which he directs. Dr. Campbell is a graduate of Case Western Reserve School of Medicine and completed his residency training at Harvard Affiliated Massachusetts General Hospital in Boston followed by his Pediatric Hematology/Oncology Fellowship at Northwestern University.

The partnership grew to become more substantial overtime, and Dr. Campbell became a Faculty Member and Mentor at the Northern Pacific Global Health Research Fellows Training Consortium in Ghana. In this position he was able to provide training for medical students and researchers, as well as further his research interests into SC phenotype and expand access to SCD treatment in the surrounding area. He also collaborated with local blood bank specialists in Ghana in order to more thoroughly understand alloimmunization rates in SCD patients who have received multiple transfusions.

Dr. Campbell also serves as a mentor to young physicians and researchers in Ghana. He has worked closely with several students, assisting them to conduct research and develop publications. One of his previous mentees, a PhD candidate in physiology, is now the Chair of Physiology at the University of Ghana Medical School. At the moment, he is on the thesis advisory panel for a masters student studying sickle cell disease.

Dr. Campbell also leads a multinational research group, the Consortium for the Advancement of Sickle Cell Disease Research (CASiRe), focused on understanding the varied phenotypic expression of sickle cell disease. The consortium collects information about pain rate and use of health care facilities during severe pain crises. This research both helps to “bridge the gap in care between developing countries and those with resources,” and helps Dr. Campbell to “improve the care of SCD patients here in the US, of which at least a third are first generation.”

Another international project Dr. Campbell is focused on is called SC Ontology, funded by Atria Africa. Dr. Campbell and his colleagues are working to develop “the first international ontology database for chronic illness.”

Departments

• Blood Disorders (Hematology)
• Center for Cancer and Blood Disorders
• Comprehensive Sickle Cell Disease Program

Education & Training

• Fellowship Program, Pediatric Hematology/Oncology, 2002
  Ann & Robert H. Lurie Children's Hospital

• Residency Program, General Pediatrics, 1999
  Massachusetts General Hospital

• Internship Program, General Pediatrics, 1997
  Massachusetts General Hospital

• MD, 1996
  Case Western Reserve University School of Medicine

• BS, 1991
  Morehouse College